2023 Dermatology Conference Recap: Part 2
Catch up on Dermatology Times conference coverage from July through December of this year.
2023 Dermatology Conferences Recap: Part 1
Catch up on Dermatology Times conference coverage from January through June of this year.
Many Patients With Moderate to Severe AD Demonstrate Inadequate Disease Control with Systemic Therapies After 3 to 12 Months of Use
The study findings were presented in a poster at the 2023 Revolutionizing Atopic Dermatitis Virtual Conference.
Rashmi Sarkar, MD, FAMS: Vitiligo and Stigma
Sarkar spoke with Dermatology Times after the ReV conference to discuss her session on vitiligo stigma.
Aesthetic Procedure Considerations for Skin of Color
Aesthetic procedures for patients with skin of color necessitate a nuanced approach that prioritizes patient safety and optimal outcomes.
ReV Up Your Vitiligo Treatment Strategies
Nanette Silverberg, MD, takes a deep dive into the importance of early intervention and gave an overview of topical care for patients of all ages with vitiligo.
Black and Deaf or Hard of Hearing Patients Face Dermatologic and Health Disparities
A poster from the RAD Virtual Conference reviewed the relationship between Black and DHH patients and the shared disparities these populations face.
Recapping the 2023 RAD and ReV Virtual Conferences
Catch up on coverage from this week's virtual Revolutionizing Atopic Dermatitis and Revolutionizing Vitiligo conferences.
All Things JAKs for Vitiligo
David Rosmarin, MD, presented new and upcoming pipeline updates for the treatment of vitiligo at the Revolutionizing Vitiligo Virtual Conference.
Raj Chovatiya, MD, PhD: Advancements in Topical Therapies for Atopic Dermatitis
At the 2023 RAD Virtual Conference, Chovatiya presented a session titled, "Living the Cream."
Dupilumab Treatment Improved Epidermal Neuroanatomy in Patients With Atopic Dermatitis
The poster was presented at the 2023 Revolutionizing Atopic Dermatitis (RAD) Virtual Conference.
5-Year Safety Data Leaves Clinicians Optimistic in Upadacitinib for AD Management
Christopher Bunick, MD, PhD, presented the research during a late-breaking research session during the 2023 Revolutionizing Atopic Dermatitis Virtual Conference.
Patient Perspective: I Am More Than My Atopic Dermatitis
Jennifer Etienne shared her experiences during the shared decision-making patient panel of the 2023 Revolutionizing Atopic Dermatitis Virtual Conference.
Association Found Between Atopic Dermatitis and Altered Oral Microbiome
A poster from the 2023 Revolutionizing Atopic Dermatitis Conference revealed a link between AD, impaired oral health, and oral dysbiosis.
Study Finds Association Between Vitiligo and Osteoporosis
A poster presented at the 2023 ReV Virtual Conference explored the association between the 2 conditions.
Alan Irvine, MD, DSc: Atopic Dermatitis and the Biological Clock
Alan Irvine, MD, DSc, discusses his Revolutionizing Atopic Dermatitis session and exciting advances in AD.
Upadacitinib for Vitiligo Improves Patient Health-Related QoL After 24 Weeks
The promising data on upadacitinib was presented at the 2023 Revolutionizing Vitiligo Virtual Conference.
The AD Tx Revolution at ACAAI
Andrew F. Alexis, MD, MPH, shared insights into using JAK inhibitors as part of the treatment revolution in atopic dermatitis at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Navigating Nutrition Support For Patients With Atopic Dermatitis
Atoosa Kourosh, MD, MPH, delves into opportunities for allergists and dermatologists to collaborate, her approach to cases, and patient resources.
Exploring Dx Issues in SOC Atopic Dermatitis at ACAAI
Ama Alexis, MD, shared the importance of recognizing diverse presentations of atopic dermatitis at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting.
.jpeg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Raj Chovatiya, MD, PhD: Advancements in Topical Therapies for Atopic Dermatitis")
